During the past decade, BMT Program at Northside Hospital conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 14 clinical trials were completed, i.e. on average, 280% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400% of trials that started reached the finish line.

Out of the total clinical trials conducted in "BMT Program at Northside Hospital" #1 sponsor was "Medical College of Wisconsin" with 11 trials, followed by "National Heart, Lung, and Blood Institute (NHLBI)" with 3 trials sponsored, "Bellicum Pharmaceuticals" with 1 trials sponsored, "Center for International Blood and Marrow Transplant Research" with 1 trials sponsored and "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "BMT Program at Northside Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 15 trials as a collaborator, "Blood and Marrow Transplant Clinical Trials Network" with 13 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 11 trials as a collaborator and "National Marrow Donor Program" with 10 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "BMT Program at Northside Hospital" are "Lymphoma" (5 trials), "Acute Leukemia" (3 trials), "Leukemia" (3 trials), "Myelodysplasia" (3 trials) and "HIV" (2 trials). Many other conditions were trialed in "BMT Program at Northside Hospital" in a lesser frequency.

Most popular intervention types in "BMT Program at Northside Hospital" are "Drug" (13 trials), "Procedure" (5 trials), "Biological" (2 trials), "Other" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cyclophosphamide" (3 trials), "Busulfan and Fludarabine" (2 trials), "Cyclophosphamide and Total Body Irradiation" (2 trials), "Fludarabine and Busulfan" (2 trials) and "Fludarabine and Melphalan" (2 trials). Other intervention names were less common.

The vast majority of trials in "BMT Program at Northside Hospital" are 17 trials for "All" genders.

Currently, there are NaN active trials in "BMT Program at Northside Hospital". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in BMT Program at Northside Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in BMT Program at Northside Hospital, 2 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".